-+ 0.00%
-+ 0.00%
-+ 0.00%

The US Patent and Trademark Office has issued Patents For Glucotrack's Continuous Blood Glucose Monitoring Platform

Benzinga·01/29/2026 13:06:52
Listen to the news

The patents strengthen Glucotrack's competitive position and intellectual property protection as the Company advances its multi-year, fully implantable CBGM system toward commercialization.

The three patents protect key technologies in Glucotrack's CBGM system, a long-term implantable device designed for multi-year sensor longevity, including proprietary sensor chemistry, intravascular lead design, and low-power electronics.

  • US 12,453,494 – Methods and Systems for Measuring Glucose Having Improved Decay Rates and Lag Times (issued Oct 28, 2025)
  • US 12,458,257 – Implantable Glucose Sensors and Methods of Glucose Measurement Configured for Minimal Sensor Surface Obstruction (issued Nov. 4, 2025)
  • US 12,458,258 – Low Power Implantable Glucose Sensors and Methods of Glucose Measurement (issued Nov. 4, 2025)